Anti-NECA3/ NECAB3/ APBA2BP functional antibody

Anti-NECA3/ NECAB3/ APBA2BP functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to NECAB3/NECAB3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1485-Ab-1/ GM-Tg-hg-SE1485-Ab-2Anti-Human NECAB3 monoclonal antibodyHuman
GM-Tg-rg-SE1485-Ab-1/ GM-Tg-rg-SE1485-Ab-2Anti-Rat NECAB3 monoclonal antibodyRat
GM-Tg-mg-SE1485-Ab-1/ GM-Tg-mg-SE1485-Ab-2Anti-Mouse NECAB3 monoclonal antibodyMouse
GM-Tg-cynog-SE1485-Ab-1/ GM-Tg-cynog-SE1485-Ab-2Anti-Cynomolgus/ Rhesus macaque NECAB3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1485-Ab-1/ GM-Tg-felg-SE1485-Ab-2Anti-Feline NECAB3 monoclonal antibodyFeline
GM-Tg-cang-SE1485-Ab-1/ GM-Tg-cang-SE1485-Ab-2Anti-Canine NECAB3 monoclonal antibodyCanine
GM-Tg-bovg-SE1485-Ab-1/ GM-Tg-bovg-SE1485-Ab-2Anti-Bovine NECAB3 monoclonal antibodyBovine
GM-Tg-equg-SE1485-Ab-1/ GM-Tg-equg-SE1485-Ab-2Anti-Equine NECAB3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1485-Ab-1/ GM-Tg-hg-SE1485-Ab-2; GM-Tg-rg-SE1485-Ab-1/ GM-Tg-rg-SE1485-Ab-2;
GM-Tg-mg-SE1485-Ab-1/ GM-Tg-mg-SE1485-Ab-2; GM-Tg-cynog-SE1485-Ab-1/ GM-Tg-cynog-SE1485-Ab-2;
GM-Tg-felg-SE1485-Ab-1/ GM-Tg-felg-SE1485-Ab-2; GM-Tg-cang-SE1485-Ab-1/ GM-Tg-cang-SE1485-Ab-2;
GM-Tg-bovg-SE1485-Ab-1/ GM-Tg-bovg-SE1485-Ab-2; GM-Tg-equg-SE1485-Ab-1/ GM-Tg-equg-SE1485-Ab-2
Products NameAnti-NECAB3 monoclonal antibody
Formatmab
Target NameNECAB3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NECAB3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1485-Ag-1Recombinant multi-species NECA3/ NECAB3/ APBA2BP protein


    Target information

    Target IDGM-SE1485
    Target NameNECAB3
    Gene ID63941,56846,311562,100427126,608658,101098703,514695,100069158
    Gene Symbol and Synonyms2900010M17Rik,APBA2BP,dJ63M2.4,dJ63M2.5,EFCBP3,NECAB3,NIP1,STIP3,SYTIP2,XB51
    Uniprot AccessionQ96P71,A2VDW6
    Uniprot Entry NameNECA3_HUMAN,NECA3_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000125967
    Target ClassificationN/A

    The target: NECAB3, gene name: NECAB3, also named as APBA2BP, EFCBP3, NIP1, STIP3, SYTIP2, XB51, dJ63M2.4, dJ63M2.5. The protein encoded by this gene interacts with the amino-terminal domain of the neuron-specific X11-like protein (X11L), inhibits the association of X11L with amyloid precursor protein through a non-competitive mechanism, and abolishes the suppression of beta-amyloid production by X11L. This protein, together with X11L, may play an important role in the regulatory system of amyloid precursor protein metabolism and beta-amyloid generation. The protein is phosphorylated by NIMA-related expressed kinase 2, and localizes to the Golgi apparatus. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.